Tenax TherapeuticsTENX +4.39%22 Market Cap is $356.50 Mil as of Jun. 27, 2026. GuruFocus rates TENX with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 1,431 Biotechnology companies, Tenax Therapeutics ranks better than 66.25% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Tenax Therapeutics's share price for the quarter that ended in Mar. 2026 was $15.99. Tenax Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 24.28 Mil. Therefore, Tenax Therapeutics's market cap for the quarter that ended in Mar. 2026 was $388.17 Mil.
Tenax Therapeutics's quarterly market cap
increased
from Sep. 2025 ($44.95 Mil) to Dec. 2025 ($113.54 Mil) and
increased
from Dec. 2025 ($113.54 Mil) to Mar. 2026 ($388.17 Mil).
Tenax Therapeutics's annual market cap
increased
from Dec. 2023 ($6.55 Mil) to Dec. 2024 ($21.18 Mil) and
increased
from Dec. 2024 ($21.18 Mil) to Dec. 2025 ($113.54 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Tenax Therapeutics's Enterprise Value for Today is $347.39 Mil.
Tenax Therapeutics (NAS:TENX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Tenax Therapeutics Market Cap Related Terms
Tenax Therapeutics Market Cap Historical Data
* Premium members only.
The historical data trend for Tenax Therapeutics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Tenax Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tenax Therapeutics Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tenax Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where Tenax Therapeutics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Tenax Therapeutics's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tenax Therapeutics (TENX) has a Market Cap of $356.50 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tenax Therapeutics and its competitors. According to the industry distribution chart, Tenax Therapeutics ranks #483 out of 1431 companies in the Biotechnology industry, placing it in the top 33.8%.
Is Tenax Therapeutics' Market Cap too high?
Tenax Therapeutics' current Market Cap is $356.50 Mil. The Biotechnology industry median Market Cap is 113.83. Tenax Therapeutics' value of $356.50 Mil is 213.2% above this industry median. Based on the distribution chart, Tenax Therapeutics ranks #483 out of 1431 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Tenax Therapeutics has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Tenax Therapeutics' Market Cap compare to RZLT and PRLD?
According to the Biotechnology industry distribution chart, Tenax Therapeutics ranks #483 out of 1431 companies for Market Cap. This puts Tenax Therapeutics in the upper half of its industry. The industry median Market Cap is 113.83. Tenax Therapeutics' value of $356.50 Mil is 213.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tenax Therapeutics's current Market Cap of $356.50 Mil is 213.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Tenax Therapeutics and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tenax Therapeutics's current Market Cap is $356.50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenax Therapeutics stock overvalued right now?
Tenax Therapeutics (TENX) has a current Market Cap of $356.50 Mil. The current Market Cap is $356.50 Mil and 213.2% above the Biotechnology industry median of 113.83. Tenax Therapeutics' overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Tenax Therapeutics (TENX), the current Market Cap is $356.50 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.
22GF Score
Get the complete analysis for TENX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TENX has been successfully added to your 
